BioMarin Pharmaceutical
S&P 400
$65.68
+0.26%
Delayed · cached 15 min
Frequently asked questions
What sector does BioMarin Pharmaceutical belong to?
BioMarin Pharmaceutical operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of BMRN?
As of the latest available quote, BMRN traded at $65.68. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of BMRN?
BioMarin Pharmaceutical has a price-to-earnings (P/E) ratio of about 177.51. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of BMRN?
The market capitalisation of BioMarin Pharmaceutical is approximately $12.73B.
Is BioMarin Pharmaceutical profitable?
For its latest reported financial year, BioMarin Pharmaceutical recorded a net profit margin of about 10.83%.
Does BMRN pay a dividend?
BioMarin Pharmaceutical does not currently show a dividend yield in our data.
What is the return on equity (ROE) of BMRN?
BioMarin Pharmaceutical has a return on equity (ROE) of about 5.52%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of BMRN?
Over the past 52 weeks, BMRN has traded between a low of $49.26 and a high of $70.98.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.